Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gottfried Doelken"'
Autor:
Judith Trotman, Sally F Barrington, David Belada, Michel Meignan, Robert MacEwan, Carolyn Owen, Václav Ptáčník, András Rosta, Günter R Fingerle-Rowson, Jiawen Zhu, Tina Nielsen, Deniz Sahin, Wolfgang Hiddemann, Robert E Marcus, Andrew Davies, Mark Hertzberg, Andrew Grigg, Paul Cannell, Hang Quach, Stephen Opat, Constantine Tam, Paula Marlton, Ann Janssens, Fritz Offner, Koen Van eygen, Randeep Sangha, Pam Mckay, Jonathan Wilson, Richard Van Der Jagt, Daryl Roitman, Marek Trneny, Jiri Mayer, Katell Le Du, Philippe Solal-Celigny, Guillaume Cartron, Charles Foussard, Norbert Frickhofen, Peter Schmidt, Ullrich Graeven, Tobias Gaska, Rudolf Schlag, Martin Sökler, Gabriele Prange-Krex, Axel Florschütz, Hans-Walter Lindemann, Christoph Schimmelpfennig, Solveig Tonndorf, Mathias Hänel, Georg Hess, Enrico Schalk, Heiko Hütten, Gottfried Doelken, Michael Pfreundschuh, Ulrich Keller, Michael Herold, Roswitha Forstpointner, Ursula Vehling-Kaiser, Martin Hoffmann, Zita Borbenyi, Miklos Udvardy, Judit Demeter, Alessandro Rambaldi, Enrica Morra, Federico Massimo, Ignazio Majolino, Monica Balzarotti, Gianpietro Semenzato, Miguel Angel Canales Albendea, Francisco Javier Peñalver Parraga, Alfonso Soler Campos, Juan Manuel Sancho Cia, Jose Antonio Marquez Navarro, Carlos Grande Garcia, Herman Nilsson-Ehle, Helen Mccarthy, Chris Pocock, Shalal Sadullah, Ram Malladi, John Radford, Ed Kanfer, Anton Kruger, Dominic Culligan, Martin Dyer, Ruth Pettengell, John Seymour, John Gribben, Saad Al-Ismail, Faris Al-Refaie, Norbert Blesing, Christopher Macnamara, Ann O'callaghan, Andrew Haynes, George Follows, Roderick Johnson, David Cunningham, Kristian Bowles, Graham Collins, Eve Gallop-Evans, Stephen Robinson, Chezhian Subash, James Bailey, Viran Holden, Jeffrey Neidhart, Moacyr De Oliveira, Haluk Tezcan, Kevin Kim, Suman Kambhampati, Keith Lanier, John Mcclean, Kensei Tobinai, Kiyohiko Hatake, Michinori Ogura, Toshiki Uchida, Kiyoshi Ando, Tomohiro Kinoshita, Thomas Höhler, Heribert Stauder, Andreas Kirsch, Michael Koenigsmann, Stephan Kremers, Thomas Illmer, Mathias Witzens-Harig, Paul La Roseé, Jan Dürig, Michael Kneba, Manfred Hensel, Stefan Fuxius, Lothar Bergmann, Kai Hübel, Christian Buske, Reinhard Marks, Gerald Wulf, Christian Lerchenmueller, Rudolf Schmits, Mark Reinwald, Eva Lengfelder, Fiona Scott, Takaaki Chou, Masafumi Taniwaki, Isao Yoshida, Kenichi Ishizawa, Naokuni Uike, Nobuhiko Uoshima, Yuri Kamitsuji, Shinsuke Iida, Ken Ohmine, Kisato Nosaka, Kazuhiko Ide, Takayuki Ishikawa, Pierre Desjardins, Nicholas Finn, Jun Zhu, Wei Li, Li Yu, Hanyun Ren, Yuan Kai Shi, Gang Wu, Xiaonan Hong, Qingyuan Zhang, Jifeng Feng, Rong Zhan, Tongyu Lin, Sirpa Leppa, Regis Costello, Adrian Tempescul, Laurence Sanhes, Olivier Tournilhac, Heinz Kirchen, Holger Hebart, Rudolf Weide, Kathleen Jentsch-Ullrich, Irit Avivi, Arnon Nagler, Ronit Gurion, Ofer Shpilberg, Pietro Leoni, Luca Baldini, Olga Samoylova, Alexandr Myasnikov, Tran-Der Tan, Hung Chang, Kyoya Kumagai, Norifumi Tsukamoto, Kunihiro Tsukasaki, Patrick Beatty, Noriko Usui, Koji Izutsu, Tohru Murayama, Tatsuo Ichinohe, Kohmei Kubo, Fumihiro Ishida, J. Thaddeus Beck, Frank Griesinger, Dzhelil Osmanov, Shaker Dakhil, Aline Clavert, Dai Maruyama, Yasuhito Terui, Kazuhito Yamamoto, Ekkehard Eigendorff, Tsutomu Kobayashi, Satoshi Ichikawa, Ilseung Choi, Katsuya Wada, Yoshitaka Kikukawa, Masao Matsuoka, Takayuki Yoshino, Yosuke Minami
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2018, 19 (11), pp.1530--1542. ⟨10.1016/S1470-2045(18)30618-1⟩
Trotman, J, Barrington, S F, Belada, D, Meignan, M, MacEwan, R, Owen, C, Ptáčník, V, Rosta, A, Fingerle-Rowson, G R, Zhu, J, Nielsen, T, Sahin, D, Hiddemann, W, Marcus, R E, Davies, A 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
PET investigators from the GALLIUM study 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
Lancet Oncology, Elsevier, 2018, 19 (11), pp.1530--1542. ⟨10.1016/S1470-2045(18)30618-1⟩
Trotman, J, Barrington, S F, Belada, D, Meignan, M, MacEwan, R, Owen, C, Ptáčník, V, Rosta, A, Fingerle-Rowson, G R, Zhu, J, Nielsen, T, Sahin, D, Hiddemann, W, Marcus, R E, Davies, A 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
PET investigators from the GALLIUM study 2018, ' Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM) : secondary analysis of a randomised, phase 3 trial ', The Lancet Oncology, vol. 19, no. 11, pp. 1530-1542 . https://doi.org/10.1016/S1470-2045(18)30618-1
BACKGROUND: Initial results from the ongoing GALLIUM trial have shown that patients with follicular lymphoma have a longer progression-free survival after first-line immunochemotherapy with obinutuzumab than with rituximab. The aim of this secondary
Autor:
Alexander S. Kekulé, Meinolf Karthaus, Peter Staib, Markus Ruhnke, Thomas Weber, Isabelle Bekeredjian-Ding, Axel Hamprecht, Philipp Koehler, Katrin Schulz, Corinna Hahn-Ast, Oliver Bader, Silke Neumann, Oliver A. Cornely, Stefan Schwartz, Peter M. Keller, Stefan W. Krause, Philippe Schafhausen, Gottfried Doelken, Michael G. Kiehl, Johannes Elias, Carolin Krämer, Paul La Rosée, Holger Rohde, Enrico Schalk, Maria J G T Vehreschild, Gerhard Haase, Maria Vergoulidou, Gerda Silling, Andrew J. Ullmann, Dieter Buchheidt
Invasive aspergillosis (IA) is a serious hazard to high-risk haematological patients. There are increasing reports of azole-resistant Aspergillus spp. This study assessed the epidemiology of IA and azole-resistant Aspergillus spp. in patients with ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f890520fc2b4b670024b2afd85eb76d8
https://www.zora.uzh.ch/id/eprint/130973/
https://www.zora.uzh.ch/id/eprint/130973/
Autor:
E. Duehmke, Peter Koch, Richard Greil, Jeremy Franklin, M. Sieber, Jürgen Wolf, Markus Loeffler, Dirk Hasenclever, Andreas Engert, Axel Georgii, Anselmo Ap, Andreas Josting, Michael Pfreundschuh, Beate Pfistner, Reinhold Munker, Hans Tesch, Volker Diehl, Gottfried Doelken, B. Lathan, Klaus-Peter Schalk, Richard Herrmann, Hartmut Kirchner, Oana Brosteanu, Ursula Paulus, U. Rueffer, T. Koch
Publikováno v:
Journal of Clinical Oncology. 20:476-484
PURPOSE: To investigate whether treatment results in intermediate-stage Hodgkin’s lymphoma can be improved by rapid application of non–cross-resistant drugs, the 10-drug regimen cyclophosphamide, vincristine, procarbazine, and prednisone (COPP),
Autor:
Norbert, Schmitz, Maike, Nickelsen, Marita, Ziepert, Mathias, Haenel, Peter, Borchmann, Christian, Schmidt, Andreas, Viardot, Martin, Bentz, Norma, Peter, Gerhard, Ehninger, Gottfried, Doelken, Christian, Ruebe, Lorenz, Truemper, Andreas, Rosenwald, Michael, Pfreundschuh, Markus, Loeffler, Bertram, Glass, N, Frickhofen
Publikováno v:
The Lancet. Oncology. 13(12)
Summary Background High-dose therapy (HDT) followed by transplantation of autologous haemopoietic stem cells is frequently done as part of first-line therapy in young patients with high-risk aggressive B-cell lymphoma. We investigated whether HDT wit
Autor:
Martin Stürmer, Lutz G. Gürtler, Hans W. Doerr, Gottfried Doelken, Emil C. Reisinger, Annemarie Berger, Carlos Fritzsche, Katrin Zimmermann, Josef Eberle
Publikováno v:
Medical Microbiology and Immunology
A transmission cluster of HIV-1 M:B was identified in 11 patients with a median age of 52 (range 26–65) in North-East Germany by C2V4 region sequencing of the env gene of HIV-1, who—except of one—were not aware of any risky behaviour. The 10 ma
Publikováno v:
Pediatric hematology and oncology. 22(8)
The authors report on 2 boys, 11(1/2) and 13 years old, who received allogeneic stem cell transplantation (alloSCT) from their HLA-identical sibling after relapse of stage IV alveolar rhabdomyosarcoma. Both patients were transplanted in a non-remissi
Autor:
Gottfried Doelken, Gianluca Gaidano, Sarit Assouline, Valeria Buccheri, Xavier Badoux, Christine McIntyre, Mike Brewster, Florence Hourcade-Potelleret, Pakeeza Sayyed, Alain Delmer
Publikováno v:
Blood. 120:1637-1637
Abstract 1637 Rituximab in combination with fludarabine and cyclophosphamide (FC) is recommended as the standard treatment for patients (pts) with chronic lymphocytic leukemia (CLL) where the goal of therapy is to achieve complete remission (ESMO Cli
Autor:
Gert J. Ossenkoppele, Vladan Vucinic, Marc Boogaerts, Georg Franke, Alois Gratwohl, Norma Peter, Michael Cross, Mathias Freund, Jan J. Cornelissen, Haifa Kathrin Al-Ali, Bob Löwenberg, Gottfried Doelken, Rainer Krahl, Dietger Niederwieser, Leo F. Verdonck, Harry C. Schouten, Thoralf Lange, Georg Maschmeyer
Publikováno v:
Blood. 118:2030-2030
Abstract 2030 HSCT after reduced or minimal intensity conditioning is increasingly used to treat AML patients not eligible for conventional HSCT. Short term outcome has been reported frequently and risk factors have been identified; long term results
Autor:
Gottfried Doelken, Michael G. Kiehl, Carsten Hirt, Norbert Grobe, Georg Maschmeyer, Dietger Niederwieser, C Busemann, Nadezda Basara, Gerhard Behre, Thomas Fischer, William Krüger, Herbert G. Sayer
Publikováno v:
Blood. 118:2014-2014
Abstract 2014 Introduction: Mantle cell lymphoma (MCL) has a poor prognosis under conventional therapy. Allo-SCT after conventional or reduced-intensity conditioning is here a promising approach. Methods: Two prospective trials were conducted to inve
Autor:
Enrica Bach, Rainer Krahl, Sabine Tschiedel, Thomas Büchner, Frank Schüler, Gottfried Doelken, Dietger Niederwieser, Thoralf Lange, Haifa Kathrin Al-Ali, Michael Cross
Publikováno v:
Blood. 118:4904-4904
Abstract 4904 Background: Prognostic molecular markers are expected to be of increasing value in stratifying treatment of patients with AML lacking cytogenetic abnormalities. While specific DNA-level mutations such as those in the FLT-3 or NPM1 genes